Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 20606162)

1.

Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Park SM, Gönen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, Taggart J, Lu Y, Deering RP, Hacohen N, Figueroa ME, Paietta E, Fernandez HF, Tallman MS, Melnick A, Levine R, Leslie C, Lengner CJ, Kharas MG.

J Clin Invest. 2015 Mar 2;125(3):1286-98. doi: 10.1172/JCI78440. Epub 2015 Feb 9.

2.

Ribosomopathies and the paradox of cellular hypo- to hyperproliferation.

De Keersmaecker K, Sulima SO, Dinman JD.

Blood. 2015 Feb 26;125(9):1377-82. doi: 10.1182/blood-2014-10-569616. Epub 2015 Jan 9.

3.

Marrow failure: a window into ribosome biology.

Ruggero D, Shimamura A.

Blood. 2014 Oct 30;124(18):2784-92. doi: 10.1182/blood-2014-04-526301. Epub 2014 Sep 18. Review.

PMID:
25237201
4.

Gene therapy cures the anemia and lethal bone marrow failure in a mouse model of RPS19-deficient Diamond-Blackfan anemia.

Jaako P, Debnath S, Olsson K, Modlich U, Rothe M, Schambach A, Flygare J, Karlsson S.

Haematologica. 2014 Dec;99(12):1792-8. doi: 10.3324/haematol.2014.111195. Epub 2014 Sep 12.

5.

p53-Independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5.

Singh SA, Goldberg TA, Henson AL, Husain-Krautter S, Nihrane A, Blanc L, Ellis SR, Lipton JM, Liu JM.

PLoS One. 2014 Feb 18;9(2):e89098. doi: 10.1371/journal.pone.0089098. eCollection 2014.

6.

The emerging roles of ribosome biogenesis in craniofacial development.

Ross AP, Zarbalis KS.

Front Physiol. 2014 Feb 4;5:26. doi: 10.3389/fphys.2014.00026. eCollection 2014. Review.

7.

Dysferlin and other non-red cell proteins accumulate in the red cell membrane of Diamond-Blackfan Anemia patients.

Pesciotta EN, Sriswasdi S, Tang HY, Speicher DW, Mason PJ, Bessler M.

PLoS One. 2014 Jan 14;9(1):e85504. doi: 10.1371/journal.pone.0085504. eCollection 2014.

8.

Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.

Garçon L, Ge J, Manjunath SH, Mills JA, Apicella M, Parikh S, Sullivan LM, Podsakoff GM, Gadue P, French DL, Mason PJ, Bessler M, Weiss MJ.

Blood. 2013 Aug 8;122(6):912-21. doi: 10.1182/blood-2013-01-478321. Epub 2013 Jun 6.

9.

Heme and FLVCR-related transporter families SLC48 and SLC49.

Khan AA, Quigley JG.

Mol Aspects Med. 2013 Apr-Jun;34(2-3):669-82. doi: 10.1016/j.mam.2012.07.013. Review.

10.
11.

Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Beurlet S, Chomienne C, Padua RA.

Haematologica. 2013 Jan;98(1):10-22. doi: 10.3324/haematol.2012.069385. Epub 2012 Oct 12. Review.

12.

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

Pant V, Quintás-Cardama A, Lozano G.

Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Review.

13.

Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro.

Moniz H, Gastou M, Leblanc T, Hurtaud C, Crétien A, Lécluse Y, Raslova H, Larghero J, Croisille L, Faubladier M, Bluteau O, Lordier L, Tchernia G, Vainchenker W, Mohandas N, Da Costa L; DBA Group of Société d'Hématologie et d'Immunologie Pédiatrique-SHIP.

Cell Death Dis. 2012 Jul 26;3:e356. doi: 10.1038/cddis.2012.88.

14.

Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia.

Gazda HT, Preti M, Sheen MR, O'Donohue MF, Vlachos A, Davies SM, Kattamis A, Doherty L, Landowski M, Buros C, Ghazvinian R, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH.

Hum Mutat. 2012 Jul;33(7):1037-44. doi: 10.1002/humu.22081. Epub 2012 Apr 16.

15.

Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.

Keel SB, Phelps S, Sabo KM, O'Leary MN, Kirn-Safran CB, Abkowitz JL.

Exp Hematol. 2012 Apr;40(4):290-4. doi: 10.1016/j.exphem.2011.12.003. Epub 2011 Dec 20.

16.

Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.

Motley WW, Seburn KL, Nawaz MH, Miers KE, Cheng J, Antonellis A, Green ED, Talbot K, Yang XL, Fischbeck KH, Burgess RW.

PLoS Genet. 2011 Dec;7(12):e1002399. doi: 10.1371/journal.pgen.1002399. Epub 2011 Dec 1.

17.

Ribosomal protein gene deletions in Diamond-Blackfan anemia.

Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, Arceci RJ, Ellis SR, Lipton JM, Bodine DM.

Blood. 2011 Dec 22;118(26):6943-51. doi: 10.1182/blood-2011-08-375170. Epub 2011 Nov 1.

18.

Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.

Zhang Q, Xiao H, Chai SC, Hoang QQ, Lu H.

J Biol Chem. 2011 Nov 4;286(44):38264-74. doi: 10.1074/jbc.M111.277012. Epub 2011 Sep 8.

19.

Cardiomyopathy is associated with ribosomal protein gene haplo-insufficiency in Drosophila melanogaster.

Casad ME, Abraham D, Kim IM, Frangakis S, Dong B, Lin N, Wolf MJ, Rockman HA.

Genetics. 2011 Nov;189(3):861-70. doi: 10.1534/genetics.111.131482. Epub 2011 Sep 2.

20.

Animal models of Diamond Blackfan anemia.

McGowan KA, Mason PJ.

Semin Hematol. 2011 Apr;48(2):106-16. doi: 10.1053/j.seminhematol.2011.02.001. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk